BioLineRx reports positive preclinical data for GLIX1 in brain cancer

Go back to BioLineRx reports positive preclinical data for GLIX1 in brain cancer
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.24 --0 (-0%)
Previous Close $3.24    52 Week High $1.63 
Open $3.24    52 Week Low $0.71 
Day High $3.24    P/E N/A 
Day Low $3.24    EPS $0.00 
Volume 10,339